Literature DB >> 15385078

Intravaginal gels as drug delivery systems.

Mary Justin-Temu1, Festo Damian, Renaat Kinget, Guy Van Den Mooter.   

Abstract

Recently, there has been a great deal of interest in the design and application of different dosage forms via the vaginal route. Several studies have proven that the vagina is an effective route for drug administration intended mainly for local action, but systemic effects of some drugs also can be attained. The major advantages of this route include accessibility, good blood supply, the ability to bypass first-pass liver metabolism, and permeability to large molecular weight drugs, such as peptides and proteins. Among the delivery systems proposed for this route is the use of intravaginal gels, which have been found to be potential vaginal drug delivery systems. The bioadhesives used in the formulation of gels play a key role in the release of the drug through the attachment to the vaginal mucosa, where the drug diffuses from the gel to the mucus.

Mesh:

Substances:

Year:  2004        PMID: 15385078     DOI: 10.1089/jwh.2004.13.834

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  16 in total

1.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

2.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

3.  Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.

Authors:  Bonnie E Lai; Marcus H Henderson; Jennifer J Peters; David K Walmer; David F Katz
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 4.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation.

Authors:  Noorullah Naqvi Mohammed; Pankaj Pandey; Nayaab S Khan; Khaled M Elokely; Haining Liu; Robert J Doerksen; Michael A Repka
Journal:  Pharm Dev Technol       Date:  2015-04-29       Impact factor: 3.133

6.  Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.

Authors:  Bonnie E Lai; Anthony R Geonnotti; Michael G Desoto; David C Montefiori; David F Katz
Journal:  Antiviral Res       Date:  2010-08-13       Impact factor: 5.970

7.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

Review 8.  Mathematical modeling of molecular diffusion through mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

Review 9.  A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.

Authors:  Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Eckhart Buchmann; David N Bayever; Leith C R Meyer
Journal:  AAPS PharmSciTech       Date:  2008-04-02       Impact factor: 3.246

10.  The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics.

Authors:  David P Wilson; Paul M Coplan; Mark A Wainberg; Sally M Blower
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.